Study objective: To validate the APACHE (acute physiology and chronic health evaluation) III unadjusted and similar hospital mortality estimate models on 30-day mortality, and to propose a simple approach to modeling local 30-day in-hospital mortality of critically ill hospitalized adults for quality management and risk-adjusted monitoring. 
T
he acute physiology and chronic health evaluation (APACHE) III system 1 provides predictions of risk of hospital or ICU mortality and has been used for quality audit purposes by the Princess Alexandra Hospital (PAH) ICU since 1994. Outcome prediction models, [1] [2] [3] [4] such as APACHE III, are used for many purposes, including assessing severity of illness, stratification of patients for research and audit, 5 and as a risk-adjustment tool in quality monitoring. Until recently, severity-of-illness measures were not advocated for the use of administering or withholding therapy. However, based on analysis of a study 6 of activated protein C in sepsis, a modified APACHE II score has been accepted as a criterion for screening patients to receive treatment with this very expensive drug. 7, 8 For quality audit, the outcome of interest in risk-of-death assessments has been survival to discharge. It is not often possible to analyze the ob-served and predicted mortality of all patients admitted to the ICU in a timely manner, due to the long length of hospital stay for some patients. Thirty-day mortality may be a more practical end point for contemporaneous quality audit, as the analysis need only be 30 days in arrears. A fixed end point, such as 30-day outcome, has been advocated 9,10 as a measure to enable comparison of mortality rates across institutions with differing hospital discharge policies.
The common underlying method of modeling ICU risk of mortality [1] [2] [3] [4] is to group and preprocess suites of observations before incorporation into the model. Acute physiologic disturbance provides most of the predictive power and is captured by summing a weighted score of deviations from normal ranges. Physiologic reserve is measured by chronologic age and scoring of chronic or comorbid patient conditions. Diagnosis, surgical status, lead-time, and individual hospital characteristics may be included in the predictive model. This study had two aims. The first was to validate the performance of APACHE III mortality estimates on short-term, 30-day, in-hospital mortality. The second was to propose a valid, simple approach to modeling local 30-day outcomes for quality audit and monitoring purposes. In this example, a logistic regression model using measures of acute physiology and physiologic reserve, with a simplified, three-level diagnostic code is used.
Materials and Methods
The data set was drawn from the 5,681 consecutive adult admissions (5,278 hospital admissions, January 1, 1995, to December 31, 1999) to the ICU of the Princess Alexandra Hospital (PAH) in Brisbane, QLD, Australia. The PAH ICU provides medical and surgical critical care services to a 700-bed adult metropolitan teaching hospital, which is the regional center for trauma, major surgery, medical subspecialties, and psychiatry. Patients admitted for Ͻ 4 h or for exclusion of myocardial infarction, cardiac surgical, burns, and age Ͻ 16 years are excluded from the study. Patient data were collected prospectively according to the rules of APACHE III, 1, 11 and included all variables necessary for calculation of the APACHE III score. Included in this set are variables associated with patient demographics, day of ICU admission, ICU length of stay, time from hospital admission until ICU admission, admission for elective surgery, emergency surgery, nonsurgical emergency, and initial diagnosis or disease group. The research was conducted on deidentified patient data with institutional ethics committee approval.
In order to fulfill the first aim, it was necessary to carefully define the end point. Thirty-day outcome was defined as a binary variable indicating patient status at 30-days. The outcomes of interest were death (the patient was deceased in the hospital within 30 days of admission) or survival (the patient was alive in the hospital at 30 days, or discharged alive from hospital within the 30 days).
The analyses excluded all ICU readmissions during an episode of hospitalization, in order to prevent double counting of outcomes. For each admission, estimates of in-hospital mortality were calculated using the APACHE III equation. 12 Details of the performance at PAH and model validation have been described elsewhere, 13, 14 where it was found that the APACHE III similar hospital models performed well in terms of calibration and discrimination. Similar hospital adjustments to the standard APACHE III model include the additional data variable of pre-ICU treatment period and information about the institution size, teaching status, region, and average length of hospitalization. In the case of the PAH, the similar hospital model references the predictions to teaching hospitals of similar size in the Midwest region of the United States.
For assessment of calibration or model fit, the agreement between predicted and observed mortality rates in risk ranges was assessed, where predicted mortality rates are based on the APACHE III estimates. Calibration curves (Fig 1) using 10 equal, contiguous risk ranges present observed against predicted outcomes. The Hosmer-Lemeshow (H-L) statistics, 15,16 C* and H*, indicate the degree of agreement between the observed and predicted mortality across risk ranges. For C*, admissions were ranked according to predicted risk of death and divided into 10 near-equal groups. H* used the sample divided into 10 contiguous deciles of risk of equal span, but unequal number. The C* and H* statistics are analogous to a Pearson 2 statistic calculated from a 4 ϫ 10 table of observed and estimated mortality and survival. For external validation studies, the degrees of freedom of the 2 distribution are the number of ranges of risk. 16 The null hypothesis of no difference between the observed and predicted frequencies across the risk ranges is rejected if p Ͻ 0.05.
Discrimination was assessed by calculating area under the receiver operating characteristic (ROC) curves and is presented with confidence intervals. 17 The area under the ROC curve estimates the probability that a randomly selected mortality will be given a higher risk-of-death estimate than a randomly selected survivor. It is a global measure of the ability of the model to assign a higher risk of death to patients who actually die. 18 To fulfill the second aim of this study, logistic regression was used to develop new models using 30-day outcome as the end point of interest. This involved two different approaches. Firstly, the APACHE III score was used in conjunction with other variables to model 30-day outcome. Secondly, the acute physiology component and the chronic health evaluation, variables that make up the APACHE III score, were used as separate features to model 30-day outcome. All variables of interest were initially entered into the model, and then a stepwise procedure was used to eliminate variables that did not significantly improve the goodness of fit of the model.
For model development and to assess reproducibility, 18 the data set was randomly divided into a developmental set containing approximately 70% of all patient cases and a test set containing the remaining 1,570 cases. Reproducibility is one important facet of generalization performance, or how well the model fits to unseen test data. Note that the H-L test of goodness of fit applied to developmental data requires degrees of freedom equal to the number of risk ranges minus 2. 16 For the test data, the degrees of freedom are equal to the number of risk ranges. The null hypothesis of no difference between the observed and predicted frequencies across the risk ranges is rejected if p Ͻ 0.05.
The variables used in modeling are shown in Table 1 . The APACHE III score, comorbidity score, and acute physiology score were all calculated as described in Knaus et al. 1 Lead time was coded as a categorical variable indicating the time from hospital admission to ICU admission. Here, admissions to the ICU the same day as admission to hospital were coded as "Ͻ 1 day," and admissions to ICU the day after hospital admission were coded as "1 day." Similarly, admissions to ICU up to 2 days after hospital admission were coded as "2 days," and the rest were coded as "Ͼ 2 days." Disease group risk category replaces an APACHE III variable with weights based on 78 diagnostic categories. Since most ICUs will see only a small number of patients in most of these disease groups, a simpler, three-level code based on the unadjusted hospital death rate in the APACHE III developmental data set (calculated from Table 3 of Knaus et al 1 ) is proposed. Each disease group was categorized as low, neutral, or high risk according to whether the mortality was higher, lower, or not significantly different from the overall sample average mortality of 17.4%. Exact two-sided binomial tests 19 using Minitab (Release 12.1; Minitab; State College, PA) tested the hypothesis for each disease group that the observed mortality was equal to 17.4%. If significantly different but Ͻ 17.4%, the disease group was coded a "low" risk of death. If significantly different from but Ͼ 17.4%, the disease group was attributed a "high" risk of death. All remaining groups were coded as "neutral." The coding for each disease group is shown in Tables 2, 3 .
Results

Description of the Data Set
There were 5,278 eligible primary adult admissions to PAH between January 1, 1995, and December 31, 1999. The average age of these patients was 53.0 years (SD, 19.0), and 62.4% were male. There were 2,302 nonoperative cases (43.6%) and 2,976 surgical cases (56.4%), comprising 2,253 elective and 723 emergency. The mean length of stay was 2.9 days (SD, 5.1) in the ICU and 27.9 days (SD, 46.6) in the hospital; overall, 780 patients (14.8%) in this data set died in the hospital.
Thirty-Day Outcome vs Hospital Outcome
All eligible ICU admissions were analyzed to compare the calibration and discrimination of the APACHE III mortality predictions on hospital outcome and 30-day outcome. Table 4 shows that the area under the ROC curves for both hospital and 30-day outcomes are almost identical, and all show excellent discrimination.
Tabulated H-L statistics for the APACHE III models of interest are also shown in Table 4 . The calibration of the unadjusted APACHE III model is Calibration curves for the unadjusted and similar hospital APACHE III models are shown in Figure 1 . For the unadjusted APACHE III model (Fig 1, top) , both the hospital and 30-day outcomes are underestimated for the 0.2 to 0.4 risk ranges and then overestimated for risk ranges between 0.5 and 0.6. Elsewhere, the model fits reasonably well with the fit of the 30-day outcome closest to the line of perfect agreement. For the similar hospital model (Fig 1,  bottom) , calibration curves for hospital and 30-day mortality overestimate mortality between risk ranges 0.5 and 0.9. Elsewhere, mortality appears to be predicted quite well. The calibration curves for 30-day outcome models lie below the curves of the in-hospital mortality models. This is expected, as patients who die within 30 days in the hospital are a subset of the in-hospital mortality group. Although the plots appear to show a difference between the observed and expected rates of mortality, only the H-L statistics for hospital mortality with the unadjusted APACHE III model indicate strong evidence of a difference between the observed and expected rates of mortality.
Development of New Models
Using the developmental data set (3,708 cases), a logistic regression equation was calculated for the two models of interest. Table 1 shows a summary of the two models. The first column of Table 1 shows all of the variables used in the modeling. The remaining columns show the odds ratios and p values associated with variables that were retained by the respective models. For readers wishing to apply these models, *Values given as odds ratio (p value) unless otherwise indicated. NI ϭ not included; NR ϭ included but not retained. †Lead time is a categoric variable indicating the time from hospital admission to ICU admission. Same-day admissions were coded as "Ͻ 1 d"; admissions to ICU the day after hospital admission were coded as "1 d"; admissions to ICU up to 2 days after hospital admission were coded as "2 d"; the remaining patients were coded as "Ͼ 2 d". ‡A list of the disease group risk categories for major disease groups may be seen in Tables 2, 3 . §Note that although this test is significant, two of the expected values were very small, which violates the assumptions for 2 procedures. After collapsing the three smallest categories, the test was no longer significant (degrees of freedom ϭ 8, 2 ϭ 14.59, p ϭ 0.067).
coefficients may be calculated by taking the natural logarithm of the odds ratios. Of the six variables initially entered, model 1 retained the APACHE III score together with age, lead time, admission type, and disease group risk category. Gender of the patient was initially entered into the model but was not retained because it did not significantly improve the goodness of fit of the model. Hip or extremity fracture Neutral *Indicates a diagnosis that did not clearly map onto a particular disease group at the time of modeling. As such, these diagnoses had no data and were given a "neutral" disease group risk category coding. 
Neutral
Other medical diseases Low *Indicates a diagnosis that did not clearly map onto a particular disease group at the time of modeling. As such, these diagnoses had no data and were given a "neutral" disease group risk category.
Model 2 used the acute physiology and comorbidity scores in place of the APACHE III score and retained five of the seven variables initially entered (age, lead time, admission type, disease group risk category, and acute physiology score were retained). Gender of the patient and comorbidity score were not retained in the model. The APACHE III system scores age by coding according to seven intervals. Model 2 was rerun using age scores instead of the continuous age variable. The resultant model did not improve the predictive ability of the model and was not considered further. Table 1 also summarizes the discrimination performance of each of the models discussed above. In all cases, the area under the ROC curve shows good discrimination, close to that shown in Table  4 for the APACHE III predictions. As expected, the areas under each of the ROC curves for the test data are slightly smaller than their developmental data counterparts. The confidence intervals for the ROC curve areas for the model discrimination on the test data overlap that for the developmental data.
Calibration analysis for each new model is also presented in Table 1 . The C* statistics imply that both new models are well calibrated for the developmental and test data. The H* statistics for model 1 are significant, although they become nonsignificant when adjustments are made for the small expected values. Assuming that this approach (which is standard in usual 2 testing) is reasonable, then the models may be interpreted as being well calibrated using H* also. Inspection of the H-L statistics suggest that the calibration of model 2 may be better than model 1 (due to the smaller 2 values). Calibration curves are shown in Figure 2 . For the developmental data (Fig 2, top) , both models deviate a little from perfect agreement although none of these deviations are large or significant (as seen by the H-L statistics). For the test data (Fig 2, bottom) , the deviations are more pronounced, and model 2 appears to be closer to the line of perfect fit. For both models, H-L statistics imply that the deviations are not significantly different from perfect fit.
Discussion
The major finding of this study is that 30-day in-hospital mortality can be used as an alternative outcome to in-hospital mortality, for the APACHE III risk of death estimates. Thirty-day outcome has advantages for contemporaneous audit of hospital mortality as all patient outcomes can be accounted for at 30 days, and a complete data set can be analyzed. There is no requirement to wait until all patients have been discharged from the hospital, nor analyze incomplete data sets where the deaths are overrepresented. This "closure of the books" is necessary so that methods such as quality audits and risk-adjusted control charting may be performed with a reproducible methodology and in a timely manner. A risk-adjusted cumulative sum, riskadjusted p chart, 20 or risk-adjusted exponentially weighted moving average chart can provide nearcontemporaneous display of 30-day risk-adjusted mortality. The use of a fixed end point such as 30-day mortality may enable the comparison of outcomes across institutions by reducing variability that may result from, for example, differing discharge policies. 9, 21 As expected, the observed mortality is lower for 30-day in-hospital mortality compared to overall in-hospital mortality. The results of the discrimination and calibration analysis showed that for the similar hospital model the predictions of 30-day in-hospital mortality were as good as, and for the unadjusted mortality model may have even been better than, the hospital mortality end point. Therefore, it is reasonable to use 30-day outcome as an end point for quality audit purposes.
The lack of posthospital follow-up of patients discharged from PAH alive is a weakness of this study, as some patients may have died after discharge but within 30 days of admission. In such a retrospective analysis, universal posthospital follow-up Ͼ 5 years was not possible. The method that has been proposed provides a practical approach; one that should not require additional data collection for most units.
The new models developed with these data are evidence that simple local models may be developed that show both good calibration and discrimination. Within the APACHE III system, the relative contributions to the predictive power of the model were as follows: acute physiology, 73.1%; disease or diagnosis, 13.6%; age, 7.3%; and chronic health items, Within the APACHE III system, the domain of physiologic reserve using comorbid disease and age contributes 20% of the APACHE III model power. 22 Johnston et al 23 found that the APACHE III weighted comorbidity score had very similar performance to alternative measures of chronic health or intercurrent conditions.
A post hoc analysis of the discrimination of the first-day APACHE II score and simplified acute physiology score II calculated on this patient data set (for both hospital outcome and 30-day outcome) were 0.84 and 0.85, respectively. Similar findings by Castella et al 24 for simplified acute physiology score II (ROC area, 0.855), APACHE II (ROC area, 0.848), and APACHE III (ROC area, 0.866) lead us to postulate that alternative measures of acute physiologic disturbance could be used, albeit with inferior model performance. The use of the simple three-level categorical disease group variable provided a dramatic simplification of the modeling process. Potentially, there may be a loss of richness and explanatory power with the simplification. However, it is impossible to have adequate patient numbers in a single institution to recalibrate all of the weights for all of the diagnostic groups. From a practical management perspective, it is desirable to continue the use of the APACHE categories from data collection since these groups provide a valuable, detailed description of unit activity and case mix, and allow a more full evaluation and interpretation of audit results. During the period of data collection, from 1995 to 1999, and the initial period of analysis, the diagnostic weights were not in the public domain. In 2003, the APACHE III mortality equations with diagnostic and other coefficients were available on the APACHE Web site (www. apache-msi.com).
Logistic regression was chosen as a modeling approach because of its well-established statistical properties and widespread use. Alternative modeling techniques are well described elsewhere, [25] [26] [27] and could be used with equal validity. In a similar study, Clermont et al 28 compared models developed with artificial neural networks and logistic regression. Similar retrospective data collected under the rules of APACHE III were used, although smaller developmental and validation samples were used. We report models that appear to have superior performance, which may be due to the inclusion of a diagnosis-related variable, a larger sample size, or a different mortality end point.
The H-L statistics are 2 -like statistics and depend on the sample size as well as the goodness of fit of the model. Large sample sizes increase the power of the analysis, and will more commonly result in small discrepancies causing rejection of the model. 29 As such the consistent lack of p Ͻ 0.05 seen in the study using the PAH ICU data set is unusual in a data set of this size.
These models were developed using a nonrandom sample of patients, excluding certain groups such as children and cardiac surgery. It is possible that the results may only be applicable to similar units with a mixed surgical and nonsurgical population, rather than to specialty units. The similarities between the APACHE III model, the model of Johnston et al, 23 Clermont et al 28 and this study suggest that this approach, rather than the exact result, is likely to be generalizable within the adult noncardiac population, depending on data quality. It is important to determine whether this simple methodology works more widely, and researchers are encouraged to try both our modeling approach, and the established ICU models. With the APACHE III coefficients publicly available, researchers have the benefit of wider choice to develop local models for monitoring risk-adjusted outcome and clinical performance.
